TLDR Tech / AI
World First: Patient Receives High-Risk Therapy to Make Cells Young Again
US-based biotechnology company Life Biosciences has dosed its first patients with an experimental therapy designed to reverse age-related vision loss. The treatment aims to turn back aging by activating three genes in nerves that do not naturally regenerate. The hope is that a single injection of the gene therapy, along with several weeks of antibiotics, can preserve or even restore vision. The genes are controlled by a genetic switch that only turns on when patients take the antibiotic, allowing for some level of control. The study will follow participants for at least five years.
Read the full story